# DouYu International Holdings Ltd: financial statements, quarterly

DOYU · Nasdaq · CIK 1762417 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/doyu.md) · [Financials](/companies/doyu/financials.md) · [Filings](/companies/doyu/filings.md) · [Insiders](/companies/doyu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/doyu/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,157](/filings/0001193125-20-122129.md) | [809](/filings/0001193125-21-142788.md) | [699](/filings/0001193125-22-130251.md) | [586](/filings/0001104659-23-049244.md) | [625](/filings/0001104659-24-053257.md) | [139](/filings/0001410578-25-000965.md) | [252](/filings/0001104659-26-044566.md) |
| Current assets | $m | [1,230](/filings/0001193125-20-122129.md) | [1,231](/filings/0001193125-21-142788.md) | [1,134](/filings/0001193125-22-130251.md) | [1,026](/filings/0001104659-23-049244.md) | [942](/filings/0001104659-24-053257.md) | [612](/filings/0001410578-25-000965.md) | [376](/filings/0001104659-26-044566.md) |
| Total assets | $m | [1,301](/filings/0001193125-20-122129.md) | [1,365](/filings/0001193125-21-142788.md) | [1,280](/filings/0001193125-22-130251.md) | [1,181](/filings/0001104659-23-049244.md) | [1,137](/filings/0001104659-24-053257.md) | [746](/filings/0001410578-25-000965.md) | [446](/filings/0001104659-26-044566.md) |
| Current liabilities | $m | [256](/filings/0001193125-20-122129.md) | [289](/filings/0001193125-21-142788.md) | [290](/filings/0001193125-22-130251.md) | [226](/filings/0001104659-23-049244.md) | [194](/filings/0001104659-24-053257.md) | [169](/filings/0001410578-25-000965.md) | [162](/filings/0001104659-26-044566.md) |
| Total liabilities | $m | [263](/filings/0001193125-20-122129.md) | [296](/filings/0001193125-21-142788.md) | [298](/filings/0001193125-22-130251.md) | [230](/filings/0001104659-23-049244.md) | [195](/filings/0001104659-24-053257.md) | [169](/filings/0001410578-25-000965.md) | [162](/filings/0001104659-26-044566.md) |
| Shareholders' equity | $m | [1,035](/filings/0001193125-20-122129.md) | [1,063](/filings/0001193125-21-142788.md) | [982](/filings/0001193125-22-130251.md) | [951](/filings/0001104659-23-049244.md) | [942](/filings/0001104659-24-053257.md) | [577](/filings/0001410578-25-000965.md) | [284](/filings/0001104659-26-044566.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 30,178,859 at 2025-12-31, from the cover of the [20-F filed 2026-04-17](/filings/0001104659-26-044566.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.